Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Drmic D, Kolenc D, Ilic S, et al
These ratios are based on U.S
PMID 23539619
Preclinical and Clinical Investigation of a CCR5 Antagonist, AZD5672, in Patients With Rheumatoid Arthritis Receiving Methotrexate
Additive effects in published research
These outcomes were characterized by greater callus development and increased mineralization within the affected area, indicating enhanced bone continuity and strength (21)
US$ 21.51
US$ 26.01
US$ 22.92
US$ 28.87
US$ 22.61
